Clinical trial
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-Pain) Testing Phase
NCT06671132 is registered in ClinicalTrials.gov with Evon Medics LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-Pain) Testing Phase
- Lead sponsor
- Evon Medics LLC
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- October 23, 2024
- Completion date
- January 30, 2026
- Enrollment
- 220 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.